Critical Warnings & Restrictions In Canada

Basic Sinequan Information

• INN (International Nonproprietary Name): Doxepin
• Brand Names Available In Canada (English): not specified
• ATC Code: N06AA12
• Forms & Dosages: Capsules 10 mg, 25 mg, 50 mg, 75 mg, 100 mg; Oral solution 10 mg/mL; Tablets 3 mg, 6 mg (Silenor in other markets)
• Manufacturers In Canada (English): Mylan, Teva, and various local generics manufacturers (supply may vary)
• Registration Status In Canada (English): Registered as prescription only (Rx); generic approval prevalent
• OTC / Rx Classification: Prescription only (Rx)

Starting a medicine safely is the top priority for many Canadians who ask about doxepin and Sinequan.

Doxepin is a prescription-only tricyclic antidepressant in Canada and should only be started after prescriber and pharmacist review.

Absolute contraindications include known hypersensitivity to doxepin or other tricyclic antidepressants, narrow-angle glaucoma, urinary retention and recent MAOI use within 14 days.

Relative risks include older adults who are more susceptible to anticholinergic effects, severe hepatic or renal impairment, cardiac conduction disease, pregnancy and lactation, and a history of suicidality.

Elderly and Indigenous patients may have different comorbidity patterns and access barriers that affect risk and follow-up; document informed consent and consider specialist referral where appropriate.

Advise patients to avoid alcohol while taking doxepin and to review all prescription, over-the-counter and natural products with their pharmacist.

• Absolute Contraindications: Known doxepin/TCA hypersensitivity; narrow-angle glaucoma; urinary retention; MAOI within 14 days.
• Relative Risks: Older adults, severe hepatic/renal impairment, cardiac conduction disorders, pregnancy/lactation, history of suicidality.

• Pre-Prescription Screening Checklist: Obtain medication history and review for MAOI exposure in prior 14 days.
• Pre-Prescription Screening Checklist: Perform ECG if there is a cardiac history or suspected conduction disease.
• Pre-Prescription Screening Checklist: Check liver and renal function and adjust dose for impairment.
• Pre-Prescription Screening Checklist: Full medication review with pharmacist to spot interactions and anticholinergic burden.

High-Risk Groups (Elderly, Pregnant, Indigenous Health Considerations)

Elderly patients have higher sensitivity to anticholinergic and sedative effects and an increased fall risk when starting doxepin.

In elderly adults begin at a lower dose, for example 25–50 mg per day, and titrate slowly while monitoring for confusion, orthostatic hypotension, urinary retention and falls.

Pregnancy and lactation require specialist input; use doxepin only if benefits clearly outweigh risks and document shared decision-making.

Indigenous patients may face limited access to mental-health specialists and have higher comorbidity burdens such as diabetes and cardiac disease; provide culturally safe counselling and consider closer follow-up.

• Monitoring Actions For Elderly: Fall-risk assessment, orthostatic vital signs and medication reconciliation.
• Monitoring Actions For Elderly: Check for urinary symptoms, constipation and new-onset confusion.
• Monitoring Actions For Elderly: Review possible dose reduction to 25–50 mg/day initially and schedule early follow-up.

Recommend documented shared decision-making and pharmacy-led follow-ups within one to two weeks of starting therapy.

Interaction With Activities (Driving, Machinery, Workplace Safety Under Canadian Law)

Doxepin commonly causes sedation, slowed reaction time and blurred vision, which can impair driving and the operation of heavy machinery.

Employees in safety-sensitive roles should follow provincial occupational health rules and disclose impairment risks to occupational health when required.

Start at lower doses and consider dosing at night to reduce daytime sedation when clinically appropriate.

• Patient Counselling Checklist: Do not drive or operate heavy machinery until you know how doxepin affects you.
• Patient Counselling Checklist: Avoid alcohol and other sedating substances while taking doxepin.
• Patient Counselling Checklist: Test household tasks and driving in a safe environment before resuming normal activity.

Q&A — “Can I Drive After Taking It In Canada?”

Short answer: No until you know how it affects you.

If you feel drowsy, dizzy or have blurred vision do not operate vehicles or heavy machinery.

Document this advice clearly in the pharmacy record.

Usage Basics For Canadians

In Canada doxepin is prescription-only and is most commonly supplied as generics from manufacturers such as Mylan and Teva.

Health Canada requires marketed prescription medicines to have a Drug Identification Number (DIN) and appropriate labelling; pharmacists verify the DIN before dispensing.

Pharmacist counselling at dispensing is essential to review dosing, side effects and interactions.

Legal Classification Under Health Canada

Doxepin is a prescription medicine in Canada and other major markets and is not available over the counter.

• Dispensing Requirements: Prescription verification and record entry in the patient medication record.
• Dispensing Requirements: Confirm the product DIN and that labelling meets bilingual requirements where applicable.
• Dispensing Requirements: Provide pharmacist counselling at each new prescription or dose change.

Canadian Dosing Guide

• Titration Checklist: Baseline ECG if there is known cardiac disease or significant CV risk.
• Titration Checklist: Watch closely for anticholinergic effects such as dry mouth, blurred vision and urinary retention.
• Titration Checklist: Schedule follow-ups at one to four weeks after initiation or dose change.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Take a missed dose as soon as you remember unless it is close to the next dose, in which case skip the missed dose.

Do not double doses to make up for a missed one.

For coverage or refill problems under provincial plans such as ODB, PharmaCare or RAMQ contact your pharmacy; pharmacists often arrange short emergency supplies under provincial authority.

Interaction Chart (Canadian Context)

Checklist: Bring all prescription, OTC and natural products to the pharmacy for a complete interaction review.

Food And Drinks (Coffee, Alcohol In Canadian Lifestyle)

Avoid alcohol while taking doxepin because it potentiates sedation and orthostatic effects.

Moderate caffeine intake may reduce sedation but can worsen anxiety in some people; it is not a direct pharmacokinetic interaction with doxepin.

• Lifestyle Counselling: No alcohol before safety-sensitive tasks or driving.
• Lifestyle Counselling: Limit or monitor caffeine if anxiety symptoms increase.

User Reports & Trends In Canada

Many Canadian patients report that doxepin is sedating and causes dry mouth, which are the most commonly mentioned tolerability issues on patient forums.

Doxepin is less commonly used as a first-line antidepressant compared with SSRIs, but it remains an option for treatment-resistant cases or when antihistaminic effects are desired for sleep at low doses.

Pharmacists report adherence problems related to sedation and anticholinergic side effects rather than issues of addiction; doxepin is not habit-forming but abrupt cessation may cause withdrawal symptoms.

• Common User-Reported Effects: Drowsiness, dry mouth, constipation, dizziness and weight gain.
• Clinical Recommendation: Use validated patient-reported outcome measures and document adverse events to Canada Vigilance when appropriate.

Canadian Patient Forums And Review Platforms

Monitor local forums for real-world reports but prioritise evidence and regulatory guidance when making clinical decisions.

• Clinician Checklist: Verify the source of the anecdote, check for serious adverse events and escalate or report to provincial ADR pathways as needed.
• Patient Advice: Direct patients to Health Canada and provincial health sites for authoritative information.

Access & Purchase Options

National chains such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu dispense generics and can assist with renewals and coverage checks.

In our online pharmacy, sinequan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

• Patient Pickup Checklist: Bring your provincial health card, valid prescription, and a current list of medications.
• Patient Pickup Checklist: Confirm the DIN at pickup and ask for counselling on side effects and storage.

Online Pharmacies In Canada & Provincial Restrictions

Legitimate Canadian online pharmacies require a prescription and must display their licence information.

• Red Flags For Illegitimate Sellers: No licence displayed, no prescription required, prices that look too good to be true.
• Safe Practice: Use licensed Canadian pharmacies and verify DIN and pharmacist contact details before ordering.

Mechanism & Pharmacology

Doxepin is a tricyclic antidepressant that inhibits the reuptake of norepinephrine and serotonin while also producing strong antihistaminic (H1) and anticholinergic effects.

The antihistaminic action explains why low doses can be sedating and useful for sleep in some settings, while the anticholinergic activity produces common side effects such as dry mouth, blurred vision and urinary retention.

Doxepin is classified under ATC code N06AA12 and is metabolized by hepatic enzymes, with variable half-life that supports careful titration and monitoring.

• Clinical Note: Account for anticholinergic burden when prescribing to older adults and those with cardiac disease.
• Technical Box For Clinicians: Mechanism: Norepinephrine and serotonin reuptake inhibition; ATC: N06AA12; Anticholinergic score: high; Metabolism: CYP450 pathways (variable).

Simplified Explanation (Patient-Friendly)

Doxepin helps balance chemicals in the brain that affect mood and sleep but can make you sleepy and dry-mouthed.

• Antidepressant Effect: Helps with mood by increasing serotonin and norepinephrine availability.
• Sedation: Strong antihistamine effect causes sleepiness, which can be useful at low doses for insomnia.
• Anticholinergic Effects: May cause dry mouth, constipation, blurred vision and urinary retention.

Indications & Off-Label Uses In Canada

When using doxepin off-label document the rationale, obtain informed consent and schedule monitoring for adverse effects.

Approved Indications (DIN)

Always confirm the product DIN and consult the product monograph for the exact approved indications and dosing for the specific formulation being dispensed.

• Verification Checklist: Check the Health Canada Drug Product Database for DIN and monograph details before prescribing or dispensing.
• Verification Checklist: Note that generics may have different packaging or manufacturer information even if the active ingredient and dosing are equivalent.

Key Clinical Findings

Doxepin efficacy for depression is supported by older randomized controlled trials, but contemporary guidelines generally favour SSRIs as first-line agents due to better tolerability.

Low-dose doxepin shows efficacy for insomnia through strong H1 antagonism as evidenced by trials supporting Silenor dosing at 3–6 mg nightly.

Post-marketing safety monitoring continues to highlight anticholinergic burden and cardiac risks, especially in the elderly and those with pre-existing cardiac disease.

• Outcome Domains: Efficacy for depression, efficacy for low-dose insomnia, tolerability concerns (sedation, anticholinergic effects), safety signals (cardiac arrhythmias, seizures).
• Clinical Tip: Consult the latest monographs and Health Canada advisories when making prescribing decisions.

Ongoing Health Canada Safety Monitoring

Report suspected adverse drug reactions to Canada Vigilance and encourage patients to seek urgent care for arrhythmia symptoms or seizures.

• ADR Reporting Checklist: Document patient details, drug, dose and description of the event, then submit to Canada Vigilance as per provincial guidance.
• Urgent Signs: New chest pain, fainting, severe palpitations, seizures, severe rash or signs of major allergic reaction.

Alternatives Matrix

• Patient-Facing Pros/Cons Checklist: Doxepin offers sedative benefit but more anticholinergic effects; SSRIs are usually better tolerated and preferred first-line.
• Clinical Note: TCAs such as doxepin remain options when SSRIs fail or are not tolerated.

Comparable Medicines With DIN In Canada

Common alternatives include amitriptyline, nortriptyline, sertraline and fluoxetine; verify DINs and monographs for each product before prescribing.

• Prescriber Quick Reference: Check the provincial formularies and product monographs for DIN-specific approvals and dosing.

Common Questions From Canadian Patients

Is Doxepin Addictive?

No, doxepin is not considered addictive, but abrupt cessation can cause withdrawal or rebound symptoms, so taper gradually under medical supervision.

What Side Effects Should Prompt Emergency Care?

Seek emergency care for severe drowsiness with breathing difficulty, chest pain, fainting, severe palpitations or seizures.

Can I Drink Alcohol?

No, patients should avoid alcohol while taking doxepin because it increases sedation and orthostatic effects.

How Long Until It Works?

Mood improvements often take one to three weeks, while low-dose insomnia benefits may appear sooner.

• When To Call Emergency Services: Severe chest pain, fainting, difficulty breathing, seizures or signs of major allergic reaction.
• When To See Prescriber: Worsening mood, new suicidal thoughts, intolerable side effects or suspected interactions.

Coverage & Purchase Comparison Table

Below is a framework to help check provincial coverage for doxepin; specific listings change frequently so contact the provincial plan for current status.

Step-by-step Purchasing Checklist: Verify the prescription, confirm the product DIN, check your provincial formulary and ask the pharmacist about generic substitution to reduce cost.

Pharmacies such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu routinely assist with coverage checks and renewal processes.

Step-By-Step Purchase Checklist For Canadian Patients

• Have your provincial health card and a valid prescription ready.
• Bring a current medication list and ask the pharmacist to verify the DIN.
• Confirm provincial coverage and co-pay amounts before filling.
• Request generic substitution if cost is an issue and ask for counselling at pickup.

Registration & Regulation

Health Canada approves prescription antidepressants with a Notice of Compliance (NOC) and assigns a Drug Identification Number (DIN) for marketed products.

Products must comply with monograph requirements and labelling rules, including bilingual labelling where mandated.

• Manufacturers: Mylan and Teva are among global suppliers of doxepin; local generics may be supplied by other manufacturers.
• Post-Market: Health Canada monitors safety through adverse reaction reporting and communications to healthcare professionals.

DIN Number And Labelling Requirements

Pharmacists should verify the DIN, expiry date and lot number at dispensing and ensure labelling meets provincial bilingual requirements when applicable.

Patients are advised to keep original packaging for travel and in case of adverse events reporting.

Storage & Handling

Store doxepin at room temperature between 15–30°C (59–86°F) and protect it from moisture and excessive heat.

Transport medications in their original packaging to maintain labelling and avoid contamination.

• Household Safe Storage: Keep locked away from children and pets and store in a cool, dry place.
• Travel Checklist: Carry the original container, prescription and an emergency letter from your prescriber when travelling.
• Disposal: Return unused or expired medicines to the pharmacy take-back program for safe disposal.

Cold-Chain Requirements (Where Applicable)

Most doxepin oral forms do not require refrigeration; check the product monograph for any specific storage instructions for oral solutions.

• Confirm storage instructions for any specialty formulation prior to dispensing.

Guidelines For Proper Use

Verify the indication and perform a baseline assessment including cardiac history, concurrent medications and pregnancy status before starting doxepin.

Consider an ECG if there is known cardiac disease or risk factors for conduction abnormalities.

Start at the lowest effective dose and titrate upward as clinically necessary while counselling about anticholinergic side effects and fall prevention.

• Follow-Up Schedule: Arrange follow-up at one to four weeks after initiation and more frequently in high-risk patients.
• Discontinuation Plan Checklist: Taper gradually to minimise withdrawal symptoms and avoid abrupt cessation.
• Monitoring Parameters Table: Monitor blood pressure and orthostatic vitals, urinary symptoms, mood and suicidality screening at each follow-up.

Encourage reporting of adverse events to Canada Vigilance and document all counselling and monitoring in the pharmacy record.

Delivery Across Canada (English)